SEC Filing Details

Form
SCHEDULE 13G
Filing Date
October 6, 2026
Document Date
October 6, 2026
Form Description
SCHEDULE 13G - Description
Filing Group
Other
Company
Atea Pharmaceuticals, Inc.
Issuer
Atea Pharmaceuticals, Inc.

Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment.

Copyright © 2026 By Atea Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy | Terms of Use